Updating of the prevalence of congenital anomalies among resident births in the municipality of gela (Southern Italy);Aggiornamento della prevalenza di anomalie congenite tra i nati residenti nel comune di gela

Epidemiologia e Prevenzione

Volumn 38, Issue 3-4, 2014, Pages 219-226

  Bianchi, Fabrizio ^a   Bianca, Sebastiano ^b   Barone, Chiara ^b   Pierini, Anna ^a  

^a CNR   (Italy)

^b ARNAS Garibaldi Nesima   (Italy)

Author keywords

Congenital anomalies; Endocrine disruptors; Hypospadias; Polluted site

Indexed keywords

CONGENITAL ABNORMALITIES; HUMAN; ITALY; NEWBORN; PREVALENCE;

CONGENITAL ABNORMALITIES; HUMANS; INFANT, NEWBORN; ITALY; PREVALENCE;

EID: 84974686687     PISSN: 11209763     EISSN: 23851937     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Per anomalia congenita si intende una qualunque anomalia della struttura o della funzione presente alla nascita e di origine prenatale. Sinonimi che sono spesso utilizzati sono «difetti alla nascita» e «mal-formazioni congenite», ma quest’ultimo ha un significato più speci-fico. Nel testo verrà utilizzato il termine «anomalia congenita»
2. World Health Organization. Births defects surveillance. A manual for programme managers. Geneva, WHO, 2014. Disponibile all’indirizzo: http://apps.who.int/iris/bitstream/10665/110223/1/9789241548724_eng.pdf
3. Bianchi F, Bianca S, Dardanoni G, Linzalone N, Pierini A. Congenital malformations in newborns residing in the municipality of Gela (Sicily, Italy). Epidemiol Prev 2006;30(1):19-26.
4. Istituzione del Registro regionale delle malformazioni congenite da parte della Regione Sicilia. DA n.3057 del 16.12.2009. Gazzetta ufficiale Regione Sicilia n.5 del 05.02.2010
5. European surveillance of congenital anomalies – EUROCATT. Disponibile all’indirizzo: http://www.eurocat-network.eu/
6. Boyd PA, Haeusler M, Barisic I, Loane M, Garne E, Dolk H. Paper 1: The EUROCAT Network – organization and processes. Birth Defects Res A Clin Mol Teratol 2011;91 Suppl1:S2-15.
7. Musmeci L, Bianchi F, Carere M, Cori L. Ambiente e salute a Gela: stato delle conoscenze e prospettive di studio. Epidemiol Prev 2009;33(3) Suppl 1:7-12.
8. Bianchi F, Minoia C, Minichilli F et al. Biomonitoring studies: bioac-cumulation of PCB and heavy metals. In: Mudu P, Martuzzi M, Terracini B (eds). Human health in areas with industrial contamination. Copenhagen, WHO, 2014. In press.
9. Bustaffa E, Minichilli F, Bianchi F. Studi su marcatori di esposizione ed effetto precoce in aree con inquinamento da arsenico: metodi e risultati del progetto SEPIAS. Epidemiol Prev 2014;38(3-4) Suppl 1.
10. 10.Cernigliaro A, Pollina Addario S, Cesaroni G et al. Stato di salute nelle aree a rischio ambientale della Sicilia – Aggiornamento dell’analisi della Mortalità (anni 1995-2002) e dei ricoveri ospedalieri (anni 2001-2006). Notiziario dell’Osservatorio Epidemiologico Regionale – Regione Siciliana. Numero monografico, luglio 2008, p. 88.
11. 11.Pirastu R, Zona A, Ancona C et al. Mortality results in SENTIERI Project. Epidemiol Prev 2011;35(5-6) Suppl 4:29-152.
12. 12.Pasetto R, Zona A, Pirastu R et al. Mortality and morbidity study of petrochemical employees in a polluted site. Environ Health 2012; 11:34.
13. 13.Guerriero C, Bianchi F, Cairns J, Cori L. Policies to clean up toxic industrial contaminated sites of Gela and Priolo: a cost-benefit analysis. Environ Health 2011,10:68.
14. 14.Bianchi F, Bianca S, Linzalone N, Madeddu A. Sorveglianza delle malformazioni congenite in Italia: un approfondimento nella Provincia di Siracusa. Epidemiol Prev 2004;28(2):87-93.
15. 15.Bianchi F, Musmeci L, Carere M, Cori L. Ambiente e salute a Gela: stato delle conoscenze e prospettive di studio. Epidemiol Prev 2009;33(3) Suppl 1:1-160.
16. 16.Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. Prioritization of Toxic Air Contaminants Under the Children’s Environmental Health Protection Act. Final Report. October 2001.
17. 17.EU Health Programme, World Health Organization. EUROCAT Guide 1.3 and reference documents. Instructions for the Registration and Surveillance of Congenital Anomalies. Newtonabbet, University of Ulster, 2005. Disponibile all’indirizzo: http://www.eurocat-network. eu/content/EUROCAT-Guide-1.3.pdf
18. 18.Coding of EUROCAT Subgroups of Congenital Anomalies. Disponibile all’indirizzo: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3-Chapter-3.3-old-version.pdf
19. 19.EUROCAT. Prevalence Tabels. Disponibili all’indirizzo: http://www. eurocat-network.eu/accessprevalencedata/prevalencetables
20. 21.Baldacci S, Pierini A, Santoro M, Spadoni I, Bianchi F. Prevalenza e mortalità dei difetti cardiaci congeniti idal Registro toscano, 1992-2009. Epidemiol Prev, 2014 (in revisione).
21. 20.Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123(8):841-9.
22. 22.Nassar N, Abeywardana P, Barker A, Bower C. Parental occupational exposure to potential endocrine disrupting chemicals and risk of hypospadias in infants. Occup Environ Med 2010;67(9):585-9.
23. 23.Ghirri P, Scaramuzzo RT, Bertelloni S et al. Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study. Ital J Pediatr 2009;35:18.
24. 24.Fisch H, Lambert SM, Hensle TW, Hyun G. Hypospadias rates in New York State are not increasing. J Urol 2009;181(5):2291-4.
25. 25.Mavrogenis S, Czeizel AE. Trends in the prevalence of recorded isolated hypospadias in Hungarian newborn infants during the last 50 years – a population-based study. Reprod Toxicol 2013;42:251-5.
26. 26.Nordenvall AS, Frisén L, Nordenström A, Lichtenstein P, Nordenskjöld A. Population based nationwide study of hypospadias in Sweden, 1973 to 2009: incidence and risk factors. J Urol 2014;191(3):783-9.
27. 27.Canon S, Mosley B, Chipollini J, Purifoy JA, Hobbs C. Epidemiological assessment of hypospadias by degree of severity. J Urol 2012;188(6):2362-6.
28. 28.Bianca S, Li Volti G, Caruso-Nicoletti M et al. Elevated incidence of hypospadias in two sicilian towns where exposure to industrial and agricultural pollutants is high. Reprod Toxicol 2003;17(5):539-45.
29. 29.Rocheleau CM, Romitti PA, Dennis LK. Pesticides and hypospadias: a meta-analysis. J Pediatr Urol 2009;5(1):17-24.
30. 30.Ormond G, Nieuwenhuijsen MJ, Nelson P et al. Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of hypospadias: case-control study. Environ Health Perspect 2009;117(2): 303-7.
31. 31.Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgeness syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol 2010;88(10):910-9.
32. 32.Giordano F, Abballe A, De Felip E et al. Maternal exposures to endocrine disrupting chemicals and hypospadias in offspring. Birth Defects Res A Clin Mol Teratol 2010;88(4):241-50.
33. 33.Carmichael SL, Yang W, Roberts EM et al. Hypospadias and residential proximity to pesticide applications. Pediatrics 2013;132(5): e1216-26.
34. 34.Shih EM, Graham JM Jr. Review of genetic and environmental factors leading to hypospadias. Eur J Med Genet 2014;pii:S1769-7212(14)00044-5.
35. 35.Thorup J, Nordenskjöld A, Hutson JM. Genetic and environmental origins of hypospadias. Curr Opin Endocrinol Diabetes Obes 2014; 21(3):227-32.
36. 36.Bleich S, Lenz B, Ziegenbein M et al. Epigenetic DNA hypermethy-lation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res 2006;30(4):587-91.
37. 37.Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 2007;23(3):297-307.
38. 38.Balabani D, Rupnik M, Klemeni AK. Negative impact of en-docrine-disrupting compounds on human reproductive health. Reprod Fertil Dev 2011;23(3):403-16.